Show summary Hide summary
A new analysis from the American Cancer Society shows a worrying shift: colorectal cancer is increasingly striking younger adults and has become the top cancer killer for people under 50. The trend alters how clinicians and public-health officials think about screening, prevention and research priorities right now.
The report, released this year in CA: A Cancer Journal for Clinicians, notes that while older adults have seen declines in colorectal cancer rates, people under 65 are experiencing rises in diagnoses. Those 65 and younger now account for roughly 45% of newly diagnosed cases — up from about 27% in 1995 — a jump experts say demands immediate attention.
Rising incidence among younger adults
Incidence is climbing fastest in the 20–49 age group, at an estimated 3% per year. For adults 50 and younger, the disease is frequently discovered late: three out of four such patients are diagnosed at an advanced stage.
Iran crisis raises immediate risks: Trump’s oil-first foreign policy in jeopardy
Aroma Park mass draws community and faith leaders: photos from the gathering
Half of all cancers in the under-50 cohort are identified in people aged 45 to 49. Despite eligibility for routine screening in that window, uptake remains low; only about 37% of people in the 45–49 age bracket have undergone recommended screening tests.
Rectal cancer is becoming more common
Another notable shift: tumors in the rectum now represent roughly one-third of colorectal cancer cases (about 32%), compared with about 27% two decades ago. That relocation of disease burden has implications for symptoms, treatment plans and outcomes.
Rebecca Siegel, lead author of the report and senior scientific director for surveillance research at the American Cancer Society, warns that the pattern of rising deaths among younger adults points to environmental or behavioral exposures that require deeper study. She called for faster progress on research and broader efforts to detect disease earlier.
Key figures at a glance
- New cases expected this year: ~158,850
- Estimated deaths this year: ~55,230
- Share of new cases in people ≤65: ~45%
- Rectal cancer share: ~32%
- Advanced-stage diagnoses in ≤50: ~75%
- Screening rate for ages 45–49: ~37%
- Five-year survival if detected early (local stage): ~95%
More than half of colorectal cancers are linked to modifiable risk factors, according to the analysis. The researchers point to poor diet, heavy alcohol use, cigarette smoking, physical inactivity and excess body weight as major contributors.
“This report makes clear that prevention and screening can no longer be focused only on older adults,” said Dr. William Dahut, the American Cancer Society’s chief scientific officer. He emphasized both the need for eligible adults to begin screening at recommended ages and for sustained research funding to develop better treatments.
For clinicians and health systems, the findings stress two urgent tasks: increase awareness of symptoms among younger patients and improve screening participation for people in their mid-40s. For individuals, the takeaways are equally concrete — address lifestyle risks where possible and talk with a provider about screening if you are 45 or older or have symptoms.
Public-health officials and clinicians say further investigation is needed to pinpoint what is driving these generational increases. In the near term, the combination of earlier detection and prevention through behavior change offers the clearest path to reducing avoidable deaths.
